Elevating Care in Resectable Stage I-III NSCLC: Targeted Therapy and Immunotherapy at the Forefront of Multimodal Treatment Strategies
Chair and Presenters Roy S. Herbst, MD, PhD, Tina Cascone, MD, PhD, and Tetsuya Mitsudomi, MD, PhD, ...
7 slides
88
Education
PeerView